Prediction of BK Virus Reactivation in Kidney Transplant Recipient

计划入组 80 人 · 首次发布于 2024 年 1 月 23 日

Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient

计划入组 18 人 · 首次发布于 2018 年 7 月 3 日

Evaluation of Renal Pretransplant Serology for BK Virus on the Risk of Post-transplant Viral Reactivation

计划入组 378 人 · 首次发布于 2020 年 8 月 10 日

BK virus-specific T-cell therapy (MD Anderson Cancer Center)

BK virus therapy (IDBiologics)

multivalent BK virus vaccine

HAMILTON CDN BK MEAN RVSON IDX ETF UNIT

United States

HAMILTON CDN BK EQUAL-WEIGHT INDEX UNIT CL E

Assembly Biosciences

United States

SpikImm Secures Worldwide License for Anti-BK Virus Monoclonal Antibodies to Protect Transplant Patients

Aicuris Reports Positive Phase 2 Results for Pritelivir in Refractory HSV Infections and Favorable Phase 1 Safety Data for AIC468

Asahi Kasei Acquires German Antiviral Specialist Aicuris for €780 Million to Expand Infectious Disease Portfolio